We analyzed IL-13Rα2 mRNA expression from primary tumor patient samples obtained from the Repository for the Molecular Brain Neoplasia Data (REMBRANDT) of the National Cancer Institute. The gene discussed is IL13RA2; the disease is neoplasm.